Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Zymeworks Inc
About ZYME
Zymeworks Inc. is a global biotechnology company building a diversified portfolio of healthcare assets. The Company's asset and royalty aggregation strategy combines a portfolio of commercial and near-commercial assets, including YUPELRI (revefenacin), with a differentiated internal research and development engine. The Company's portfolio also includes Ziihera (zanidatamab-hrii), a HER2-targeted bispecific antibody discovered and developed by it and commercialized through global partnerships with Jazz Pharmaceuticals and BeOne Medicines, and pasritamig, a clinical-stage multispecific antibody developed by Johnson & Johnson using the Company's proprietary antibody engineering technologies. The Company is advancing a diverse pipeline of novel biotherapeutics, leveraging its proprietary Azymetric platform and expertise in antibody-drug conjugates, multispecific antibodies and other next-generation antibody technologies. Its product candidates include ZW191, ZW251, ZW220, ZW209 and ZW1528.
Find out what a historical investment in Zymeworks Inc would be worth today using our ZYME stock calculator.
Market Capitalisation
$1.88B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.37M
High today
$26.24
Low today
$25.00
Open price
$26.24
52-week high
$31.34
52-week low
$16.00
Ready to start your investing journey with Stake?
Open an accountHow do I buy ZYME shares in Australia?
Buying ZYME shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Zymeworks Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ZYME
What is the ticker symbol of Zymeworks Inc?
The ticker symbol for Zymeworks Inc is ZYME.
How much is one share of ZYME?
One share of ZYME is valued at $25.31 as of 09 October 2026.
What is the market capitalisation of Zymeworks Inc ZYME?
As of 09 October 2026 Zymeworks Inc has a market cap of $1.88B.
What is the 52-week high for Zymeworks Inc stock?
The Zymeworks Inc 52-week high stock price is $31.34.
What is the 52-week low for Zymeworks Inc stock?
The Zymeworks Inc 52-week low stock price is $16.00.
Can I buy ZYME shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ZYME shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ZYME on Stake
- Buy ZYME from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ZYME from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ZYME related stocks